Tyme Technologies GAAP EPS of -$0.03

Feb. 11, 2022 6:52 AM ETTyme Technologies, Inc. (TYME)By: Niloofer Shaikh, SA News Editor
  • Tyme Technologies press release (NASDAQ:TYME): FQ3 GAAP EPS of -$0.03.
  • The company is on track for mid-2022 full enrollment of HopES trial for SM-88 used in patients with high-risk Ewing’s and other sarcoma types.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.